Abstract |
The in vivo antiviral activity of the Keggin polyoxotungstate PM-19 [K7(PTi2W10O40).6H2O] against herpes simplex virus type 2 (HSV-2) was investigated in mice immunosuppressed by cyclophosphamide (CY). When PM-19 was administered intraperitoneally to immunosuppressed mice for 3 days (once daily) starting at the time of infection, it prevented death due to HSV-2 encephalitis in a dose-dependent manner (10-25 mg/kg). The in vivo anti-HSV-2 activity of PM-19 was superior to that of acyclovir. Intraperitoneal administration of PM-19 to the immunosuppressed mice significantly increased the number of peritoneal cells, especially macrophages. PM-19 did not stimulate interferon-inducing activity or natural killer cell activity, but markedly enhanced peritoneal macrophage functions: (1) phagocytic activity as assessed by measuring the amount of 51Cr-labeled sheep red blood cells taken into the macrophages, and (2) extrinsic antiviral activity as monitored by reduction in the numbers of plaque formed upon cocultivation of HSV-2-infected HEL cells with the macrophages. These results point to the role of peritoneal macrophage activation in the activity of PM-19 against HSV-2 infection in immunosuppressed mice.
|
Authors | S Ikeda, S Nishiya, A Yamamoto, T Yamase, C Nishimura, E De Clercq |
Journal | Journal of medical virology
(J Med Virol)
Vol. 41
Issue 3
Pg. 191-5
(Nov 1993)
ISSN: 0146-6615 [Print] United States |
PMID | 8263499
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antiviral Agents
- Polymers
- Tungsten Compounds
- polyoxotungstate PM 19
- Acyclovir
|
Topics |
- Acyclovir
(therapeutic use)
- Animals
- Antiviral Agents
(therapeutic use)
- Cell Line
- Female
- Herpes Simplex
(drug therapy, immunology)
- Herpesvirus 2, Human
(drug effects)
- Humans
- Immunocompromised Host
- Killer Cells, Natural
(drug effects, immunology)
- Lung
- Lymphocyte Activation
(drug effects)
- Macrophage Activation
(drug effects)
- Macrophages, Peritoneal
(drug effects, immunology)
- Mice
- Phagocytosis
(drug effects)
- Polymers
(therapeutic use)
- Radioimmunoassay
- Tungsten Compounds
(therapeutic use)
|